ARCTURUS THERAPEUTICS HOLDINGS INC. Stock Split Ratio
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) reported Stock Split Ratio of 14.29% for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2020-03-16
- 2019-06-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month 14.29%.
- 2019-06-12: Stockholders' Equity Note, Stock Split, Conversion Ratio 100.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month |
|---|---|---|
| 2019-06-30 | 14.29% 10-Q · filed 2019-08-14 | |
| 2019-06-12 | 100.00% 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |